Graphical abstract of the performed study.

Background

In recent years, quantitative magnetic resonance imaging (MRI) made progress towards clinical applicability mainly through advances in acceleration techniques. In patients with multiple sclerosis (MS), objective quantitative MRI-based characterization of subtle pathological alterations in lesions, perilesion (PL), as well as normal-appearing (NA) white matter (NAWM) and grey matter (NAGM) would revolutionize clinical assessment. While numerous quantitative techniques have been applied in studies of MS patients, their diagnostic significance especially for individual patients with relatively short disease duration is unclear. Therefore, we investigated the sensitivity of several quantitative MRI parameters to focal and diffuse MS pathology in a clinical feasibility study with a small sample size.

Methods

In 13 MS patients with a mean disease duration of 8 years and a mean EDSS of 1.1 as well as 14 healthy age-matched controls (HC), we acquired nine (semi-)quantitative magnetic resonance (MR) biomarkers, namely myelin water fraction (MWF), magnetization transfer (MT) saturation (MTsat), inhomogeneous MT ratio (ihMTR), quantitative longitudinal relaxation time (qT1), intrinsic (qT2) and effective (qT2*) quantitative transverse relaxation times, proton density (PD), quantitative susceptibility mapping (QSM), and the ratio between T1-weighted and T2-weighted images (T1w/T2w). Four volumes of interest were automatically defined (NA/HC grey matter (GM), NA/HC white matter (WM), lesion, and PL), and biomarker values were analyzed between groups and tissue types.

Results

For all nine assessed biomarkers, mean values per patient were significantly different between lesion, PL, and NAWM (p <  0.05, FDR corrected). The lesion values of qT1, qT2, qT2 * , PD, and QSM were rather inhomogeneous. Furthermore, MWF, MTsat, and ihMTR were sensitive to diffuse WM pathology in MS with the largest absolute differences between NAWM and HCWM medians, albeit not statistically significant after correction for multiple testing.

Discussion

In our study, we successfully compared nine different quantitative MR parameters within the same subjects for tissue characterization of MS. Our study adds relevant aspects to the current debate on different sensitivities of various quantitative MR biomarkers to MS pathology. While all investigated MR biomarkers allowed characterizing lesions in individual patients, a separation of NAWM and HCWM could be most promising with the myelin-sensitive measures MWF, MTsat, and ihMTR.